# GV101 in Healthy Obese Participants

> **NCT06979505** · PHASE2 · COMPLETED · sponsor: **Graviton Bioscience Corporation** · enrollment: 131 (actual)

## Conditions studied

- Weight Management

## Interventions

- **DRUG:** GV101
- **DRUG:** GV101 placebo

## Key facts

- **NCT ID:** NCT06979505
- **Lead sponsor:** Graviton Bioscience Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-30
- **Primary completion:** 2026-01-28
- **Final completion:** 2026-01-28
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06979505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06979505, "GV101 in Healthy Obese Participants". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06979505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*